203 related articles for article (PubMed ID: 26093640)
1. Detection of cardiac sarcoidosis by macrophage-directed somatostatin receptor 2-based positron emission tomography/computed tomography.
Reiter T; Werner RA; Bauer WR; Lapa C
Eur Heart J; 2015 Sep; 36(35):2404. PubMed ID: 26093640
[No Abstract] [Full Text] [Related]
2. The Multi-modality Cardiac Imaging Approach to Cardiac Sarcoidosis.
Ricci F; Mantini C; Grigoratos C; Bianco F; Bucciarelli V; Tana C; Mastrodicasa D; Caulo M; Donato Aquaro G; Raffaele Cotroneo A; Gallina S
Curr Med Imaging Rev; 2019; 15(1):10-20. PubMed ID: 31964322
[TBL] [Abstract][Full Text] [Related]
3. Right ventricular mass: a rare presentation of cardiac sarcoidosis.
Bertic M; Tandon S; Wisenberg G
Eur Heart J; 2016 Mar; 37(11):859. PubMed ID: 26705387
[No Abstract] [Full Text] [Related]
4. Diagnosis of cardiac sarcoidosis: an era of paradigm shift.
Sharma A; Okada DR; Yacoub H; Chrispin J; Bokhari S
Ann Nucl Med; 2020 Feb; 34(2):87-93. PubMed ID: 31848928
[TBL] [Abstract][Full Text] [Related]
5. Active cardiac sarcoidosis on standard chest computed tomography.
Murphy DJ; Subesinghe M; Rashid I; Reyes-Torres E
Eur Heart J Cardiovasc Imaging; 2018 Sep; 19(9):1025. PubMed ID: 29860431
[No Abstract] [Full Text] [Related]
6. Imaging cardiac sarcoidosis by cardiac positron emission tomography (PET): a local experience using a high-fat, low-to-no carbohydrate protocol.
Koh AS; Kok TY; Sim DK; Lath N; Tan RS
Ann Acad Med Singap; 2014 Jul; 43(7):383-5. PubMed ID: 25142475
[No Abstract] [Full Text] [Related]
7. Myocardial hypoattenuation in cardiac sarcoidosis: CT correlation with CMR, PET and SPECT.
Raimondi PM; Lisker J; Rini JN; Vitkovski T; Rahmani N; Kuvin JT; Saba SG
Clin Imaging; 2020 Nov; 67():136-142. PubMed ID: 32622334
[TBL] [Abstract][Full Text] [Related]
8. Multimodality imaging in the diagnosis and management of cardiac sarcoidosis.
Manoushagian SJ; Lakhter V; Patil PV
J Nucl Cardiol; 2017 Feb; 24(1):29-33. PubMed ID: 27837455
[No Abstract] [Full Text] [Related]
9. Somatostatin receptor based PET/CT in patients with the suspicion of cardiac sarcoidosis: an initial comparison to cardiac MRI.
Lapa C; Reiter T; Kircher M; Schirbel A; Werner RA; Pelzer T; Pizarro C; Skowasch D; Thomas L; Schlesinger-Irsch U; Thomas D; Bundschuh RA; Bauer WR; Gärtner FC
Oncotarget; 2016 Nov; 7(47):77807-77814. PubMed ID: 27780922
[TBL] [Abstract][Full Text] [Related]
10. Patient selection for personalized peptide receptor radionuclide therapy using Ga-68 somatostatin receptor PET/CT.
Kulkarni HR; Baum RP
PET Clin; 2014 Jan; 9(1):83-90. PubMed ID: 25029937
[TBL] [Abstract][Full Text] [Related]
11. 68Ga-DOTATOC PET for Treatment Efficacy Evaluation of Cardiac Sarcoidosis.
Imperiale A; Poindron V; Martinez M; Ohlmann P; Schindler TH; El Ghannudi S
Clin Nucl Med; 2020 Sep; 45(9):e416-e418. PubMed ID: 32604122
[TBL] [Abstract][Full Text] [Related]
12. Role of multimodality imaging in the early identification of cardiac sarcoidosis.
Ahmed HN; Paz YE; Stuck J; Maurer M; Bokhari S
J Nucl Cardiol; 2014 Jun; 21(3):655-9. PubMed ID: 24477405
[No Abstract] [Full Text] [Related]
13. Diagnosis and treatment response evaluation of cardiac sarcoidosis using positron emission tomography/magnetic resonance imaging.
Nensa F; Tezgah E; Poeppel T; Nassenstein K; Schlosser T
Eur Heart J; 2015 Mar; 36(9):550. PubMed ID: 25538093
[No Abstract] [Full Text] [Related]
14. (18)F-FDG PET/CT for the assessment of myocardial sarcoidosis.
Skali H; Schulman AR; Dorbala S
Curr Cardiol Rep; 2013 May; 15(5):352. PubMed ID: 23504346
[TBL] [Abstract][Full Text] [Related]
15. Cardiac magnetic resonance imaging-indeterminate/negative cardiac sarcoidosis revealed by
Sasson SC; Russo R; Chung T; Chu G; Hunyor I; Williamson J; Murad A; Kane A; Riminton S; Limaye S
J Med Case Rep; 2017 Oct; 11(1):291. PubMed ID: 29052526
[TBL] [Abstract][Full Text] [Related]
16. Imaging of myocardial inflammation with somatostatin receptor based PET/CT - A comparison to cardiac MRI.
Lapa C; Reiter T; Li X; Werner RA; Samnick S; Jahns R; Buck AK; Ertl G; Bauer WR
Int J Cardiol; 2015 Sep; 194():44-9. PubMed ID: 26005805
[TBL] [Abstract][Full Text] [Related]
17. Could 68Ga-somatostatin analogues replace other PET tracers in evaluating extra-adrenal paragangliomas?
Treglia G; Giovanella L
Eur J Nucl Med Mol Imaging; 2013 Dec; 40(12):1797-9. PubMed ID: 24072348
[No Abstract] [Full Text] [Related]
18. Isolated cardiac sarcoidosis: the crucial role of multimodal imaging with positron emission tomography/magnetic resonance imaging in diagnosis and therapy surveillance.
Steger A; Weichert W; Ibrahim T; Rischpler C
Eur Heart J; 2018 Feb; 39(6):488. PubMed ID: 29182753
[No Abstract] [Full Text] [Related]
19. Somatostatin receptor-based PET/CT of intracranial tumors: a potential area of application for 68 Ga-DOTA peptides?
Sharma P; Mukherjee A; Bal C; Malhotra A; Kumar R
AJR Am J Roentgenol; 2013 Dec; 201(6):1340-7. PubMed ID: 24896203
[TBL] [Abstract][Full Text] [Related]
20. Is there an association between clinical presentation and the location and extent of myocardial involvement of cardiac sarcoidosis as assessed by ¹⁸F- fluorodoexyglucose positron emission tomography?
Mc Ardle BA; Birnie DH; Klein R; de Kemp RA; Leung E; Renaud J; DaSilva J; Wells GA; Beanlands RS; Nery PB
Circ Cardiovasc Imaging; 2013 Sep; 6(5):617-26. PubMed ID: 23884290
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
